Thomas Williams

Neuroscientist

Data updated

Papers

25 publications

Trials

0 clinical trials

Research Footprint

Thomas Williams appears in 25 tracked papers (2010–2024), most studied alongside Psilocybin, MDMA and LSD, across PTSD, Neuroimaging & Brain Measures and Depressive Disorders.

Most-cited paper: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (1178 citations).

Frequent co-authors: Robin Carhart-Harris, Monnica Williams and David Nutt.

Publication Landscape

How the 25 papers Blossom tracks for Thomas Williams line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.

How has Thomas Williams's publishing grown?

Sourced

Tracked papers by publication year. Click a year for the running total.

5papers published in 2021

+150% vs 2020

19 published by 2021

Browse papers

Don't read as total output: only the 25 of 25 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.

What does Thomas Williams publish on?

Sourced

Tracked papers per topic. Orange marks the largest research focus.

Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Where does Thomas Williams publish?

Sourced

Tracked papers per journal. Orange marks the most-used journal.

Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Background & Research

Thomas M. Williams is a neuroscientist specialising in human neuroimaging and electrophysiology of altered states of consciousness induced by psychedelic compounds. His work has focused on multi-modal characterisation of network- and signal-level changes under psilocybin and LSD, including studies linking increased global functional connectivity to subjective experiences such as ego-dissolution and identifying broadband cortical desynchronisation as a mechanistic substrate of the psychedelic state. Williams has collaborated with leading psychedelic research groups to apply functional MRI and EEG measures to both healthy volunteers and clinical populations, and to interpret those findings in the context of psychotherapy and early psychosis models.

In addition to basic neurophysiological studies, Williams has contributed to translational and clinical lines of research, including safety and tolerability assessments of MDMA-assisted psychotherapy in substance use disorders and work exploring implications of neuroimaging results for psychedelic-assisted psychotherapy. His publications and collaborative projects bridge mechanistic neuroscience, clinical trial design, and theoretical frameworks (e.g., network integration, desynchronisation/entropic accounts) that aim to explain therapeutic and adverse responses to psychedelic interventions.

Key Impact

Notable for neuroimaging and electrophysiological research that has helped characterise how classic psychedelics (psilocybin, LSD) and allied interventions alter large-scale brain dynamics and inform translational hypotheses for psychiatric disorders.

25

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

46 collaborators· click a node to visit their profile

Full network →

Collaboration Network

See Thomas Williams's full collaboration network, shared papers, and research connections.

Affiliations

Institutions, companies, and organisations Thomas Williams is associated with.